José Trevejo

José Trevejo

Plus aucun poste en cours
54 ans
Health Technology
Commercial Services
Consumer Services

Profil

Dr. José M.
Trevejo is a Chief Medical Officer at Q32 Bio, Inc. Dr. Trevejo was previously employed as a Chief Medical Officer by Tarsus Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by SmartPharm Therapeutics, Inc., a Vice President-Development by Visterra, Inc., a Medical Director by Genentech, Inc., a Medical Director by Vertex Pharmaceuticals (Canada), Inc., a Vice President-Clinical Development by Cyclerion Therapeutics, Inc., a Chief Development Officer by Rocket Pharmaceuticals, Inc., and a Principal Investigator & Scientist by The Charles Stark Draper Laboratory, Inc. He also served on the board at Diabetes Hands Foundation.
He received his undergraduate degree from the University of California, Los Angeles and a doctorate degree from Weill Cornell Medical College.

Postes actifs de José Trevejo

SociétésPosteDébut

Anciens postes connus de José Trevejo

SociétésPosteFin
TARSUS PHARMACEUTICALS, INC. Directeur Technique/Scientifique/R&D 18/01/2024
Directeur Technique/Scientifique/R&D 01/08/2014
Directeur Technique/Scientifique/R&D 01/02/2013
CYCN THERNPV Corporate Officer/Principal -
ROCKET PHARMACEUTICALS, INC. Corporate Officer/Principal -
Voir l'expérience en détail de José Trevejo

Formation de José Trevejo

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

49

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. José Trevejo
🔇